Search Within

Martin Henner Voss

Formats
  1. Meeting Abstract (150)
  2. Journal Article (122)
  3. Review (6)
  4. Editorial (5)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (288)
  2. Genitourinary Oncology Service (288)
  3. Solid Tumor Oncology Division (288)
  4. Human Oncology and Pathogenesis Program (104)
  5. Weinberg Fellows (104)
  6. Surgery (103)

More Groups

People
  1. Robert Motzer (176)
  2. Abraham Hakimi (95)
  3. Darren Feldman (80)
  4. Chung-Han Lee (75)
  5. Maria Carlo (65)
  6. Ritesh Kotecha (63)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (30)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (116)
  2. Clinical Cancer Research (18)
  3. BJU International (15)
  4. Annals of Oncology (13)
  5. Journal for ImmunoTherapy of Cancer (12)
  6. Clinical Genitourinary Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (120)
  2. American Association for Cancer Research (26)
  3. Wiley Blackwell (22)
  4. Elsevier Inc. (21)
  5. Oxford University Press (18)
  6. Biomed Central Ltd (15)

More Publishers

Results (288)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: A large single-institution experience
    Journal Article

    Bambury, R. M.; Benjamin, D. J.; Chaim, J. L.; Zabor, E. C.; Sullivan, J.; Garcia-Grossman, I. R.; Regazzi, A. M.; Ostrovnaya, I.; Apollo, A.; Xiao, H.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
    Journal Article

    Hyman, D. M.; Snyder, A. E.; Carvajal, R. D.; Gerecitano, J. F.; Voss, M. H.; Ho, A. L.; Konner, J.; Winkelmann, J. L.; Stasi, M. A.; Monson, K. R.; more...
    Cancer Chemotherapy and Pharmacology (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis
    Journal Article

    Bastos, D. A.; Molina, A. M.; Hatzoglou, V.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Identification and validation of predictive biomarkers (BM) for everolimus (EVE) in metastatic renal cell carcinoma: Analysis of 442 patients on RECORD-3
    Meeting Abstract

    Voss, M. H.; Chen, D.; Marker, M.; Hamilton, M.; Kalfoglou, C.; Hsieh, J.; Knox, J. J.; Anak, O.; Motzer, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • First-in-human phase I "basket" study of Debio1347 (CH5183284), a novel FGFR inhibitor, in patients FGFR genoinically activated advanced solid tumors
    Meeting Abstract

    Voss, M. H.; Adamo, B.; Heist, R. S.; Gandhi, L.; Moulon, C.; Tanaka, H.; Ishii, N.; Vasiln, A.; Aoki, Y.; Nicolas-Metral, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I/II study to assess the safety and efficacy of pazopanib and MK-3475 in subjects with advanced renal cell carcinoma
    Meeting Abstract

    McDermott, D. F.; Infante, J. R.; Voss, M. H.; Motzer, R. J.; Haanen, J. B. A. G.; Chowdhury, S.; Perini, R. F.; Iannone, R.; Hodge, R.; Figueroa, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B. I.; McDermott, D. F.; Razak, A. R. A.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts
    Meeting Abstract

    Atkins, M. B.; Voss, M. H.; Plimack, E. R.; Rini, B. I.; Alter, R.; Dawson, N. A.; Beck, J. T.; Bhatt, R. S.; Pappas, K. M.; Wilson, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Amin, A.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B. I.; McDermott, D. F.; Knox, J. J.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (MRCC)
    Meeting Abstract

    Hammers, H.; Plimack, E. R.; Infante, J. R.; Ernstoff, M.; Rini, B. I.; McDermott, D. F.; Razak, A.; Pal, S. K.; Voss, M.; Sharma, P.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save